Overview
Molecular imaging is a powerful tool for advancing drug development programs and is used in a clinical setting to answer biological questions regarding PK/PD, target expression and engagement, internalization and metabolism of novel therapeutics and the development of biomarker strategies. The “translatability” of molecular imaging methodologies into the clinical setting allows for the development of biomarker-based companion diagnostics to support go/no-go decisions at early clinical phases. Invicro’s combination of flexible, versatile and innovative preclinical work together with highly specialized clinical imaging experience provides the perfect toolbox for research programs interested in quickly advancing their products into the clinical setting.
